Avanos Medical Inc (AVNS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avanos Medical Inc (AVNS) has a cash flow conversion efficiency ratio of -0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.30 Million) by net assets ($782.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Avanos Medical Inc's balance sheet to measure how much of total assets are equity-financed.
Avanos Medical Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Avanos Medical Inc to evaluate the quality of earnings relative to operating cash generation.
Avanos Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avanos Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corbion NV
AS:CRBN
|
0.155x |
|
Hubei Heyuan Gas Co Ltd
SHE:002971
|
0.073x |
|
HHC Changzhou Corp.
SHE:301061
|
N/A |
|
SHANG.FOS.PHARM.GR.H YC 1
F:08HH
|
N/A |
|
RLJ Lodging Trust
NYSE:RLJ
|
0.029x |
|
T1 Energy Inc.
NYSE:TE
|
0.410x |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
|
0.025x |
|
Reit 1
TA:RIT1
|
0.006x |
Annual Cash Flow Conversion Efficiency for Avanos Medical Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Avanos Medical Inc from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Avanos Medical Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $778.20 Million | $74.70 Million | 0.096x | -21.02% |
| 2024-12-31 | $828.50 Million | $100.70 Million | 0.122x | +363.78% |
| 2023-12-31 | $1.24 Billion | $32.40 Million | 0.026x | -62.77% |
| 2022-12-31 | $1.29 Billion | $90.90 Million | 0.070x | +2.46% |
| 2021-12-31 | $1.27 Billion | $87.30 Million | 0.069x | +3553.25% |
| 2020-12-31 | $1.26 Billion | $-2.50 Million | -0.002x | +96.62% |
| 2019-12-31 | $1.27 Billion | $-74.50 Million | -0.059x | +47.54% |
| 2018-12-31 | $1.30 Billion | $-145.60 Million | -0.112x | -194.60% |
| 2017-12-31 | $1.22 Billion | $144.20 Million | 0.119x | -30.72% |
| 2016-12-31 | $1.10 Billion | $188.80 Million | 0.171x | +85.16% |
| 2015-12-31 | $1.06 Billion | $97.60 Million | 0.092x | -6.75% |
| 2014-12-31 | $1.49 Billion | $147.90 Million | 0.099x | -7.86% |
| 2013-12-31 | $2.08 Billion | $223.80 Million | 0.108x | +9.22% |
| 2012-12-31 | $2.06 Billion | $202.60 Million | 0.099x | -- |
| 2011-12-31 | $0.00 | $139.60 Million | x | -- |
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more